Ebola and Marburg Hemorrhagic Fever

被引:102
作者
Hartman, Amy L. [1 ,2 ]
Towner, Jonathan S. [3 ]
Nichol, Stuart T. [3 ]
机构
[1] Univ Pittsburgh, Reg Biocontainment Lab, Ctr Vaccine Res, Pittsburgh, PA 15261 USA
[2] Univ Pittsburgh, Grad Sch Publ Hlth, Dept Infect Dis & Microbiol, Pittsburgh, PA 15261 USA
[3] Ctr Dis Control & Prevent, Special Pathogens Branch, Div Viral & Rickettsial Dis, Atlanta, GA 30333 USA
关键词
Ebola; Marburg; Filovirus; Hemorrhagic fever; VIRUS-LIKE PARTICLES; NONHUMAN-PRIMATES; DENDRITIC CELLS; POSTEXPOSURE TREATMENT; ENDOTHELIAL-CELLS; RHESUS-MONKEYS; TISSUE FACTOR; GUINEA-PIGS; IN-VITRO; INFECTION;
D O I
10.1016/j.cll.2009.12.001
中图分类号
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号
1001 ;
摘要
Ebola and Marburg viruses cause a severe viral hemorrhagic fever disease mainly in Sub-Saharan Africa. Although outbreaks are sporadic, there is the potential for filoviruses to spread to other continents unintentionally because of air travel or intentionally because of bioterrorism. This article discusses the natural history, epidemiology, and clinical presentation of patients infected with Ebola and Marburg viruses. Clinicians in the United States should be aware of the symptoms of these viral infections in humans and know the appropriate procedures for contacting local, state, and national reference laboratories in the event of a suspected case of filoviral hemorrhagic fever.
引用
收藏
页码:161 / +
页数:19
相关论文
共 62 条
  • [1] [Anonymous], EP PAND AL RESP EPR
  • [2] [Anonymous], BIOS MICR BIOM LAB
  • [3] Defective humoral responses and extensive intravascular apoptosis are associated with fatal outcome in Ebola virus-infected patients
    Baize, S
    Leroy, EM
    Georges-Courbot, MC
    Capron, M
    Lansoud-Soukate, J
    Debré, P
    Fisher-Hoch, SP
    McCormick, JB
    McCormick, JB
    Georges, AJ
    [J]. NATURE MEDICINE, 1999, 5 (04) : 423 - 426
  • [4] BARON RC, 1983, B WORLD HEALTH ORGAN, V61, P997
  • [5] Treatment of Marburg and Ebola hemorrhagic fevers: A strategy for testing new drugs and vaccines under outbreak conditions
    Bausch, Daniel G.
    Sprecher, A. G.
    Jeffs, Benjamin
    Boumandouki, Paul
    [J]. ANTIVIRAL RESEARCH, 2008, 78 (01) : 150 - 161
  • [6] Assessment of the risk of Ebola virus transmission from bodily fluids and fomites
    Bausch, Daniel G.
    Towner, Jonathan S.
    Dowell, Scott F.
    Kaducu, Felix
    Lukwiya, Matthew
    Sanchez, Anthony
    Nichol, Stuart T.
    Ksiazek, Thomas G.
    Rollin, Pierre E.
    [J]. JOURNAL OF INFECTIOUS DISEASES, 2007, 196 : S142 - S147
  • [7] Ebola and Marburg viruses replicate in monocyte-derived dendritic cells without inducing the production of cytokines and full maturation
    Bosio, CM
    Aman, MJ
    Grogan, C
    Hogan, R
    Ruthel, G
    Negley, D
    Mohamadzadeh, M
    Bavari, S
    Schmaljohn, A
    [J]. JOURNAL OF INFECTIOUS DISEASES, 2003, 188 (11) : 1630 - 1638
  • [8] 3-deazaneplanocin A induces massively increased interferon-α production in Ebola virus-infected mice
    Bray, M
    Raymond, JL
    Geisbert, T
    Baker, RO
    [J]. ANTIVIRAL RESEARCH, 2002, 55 (01) : 151 - 159
  • [9] Ebola virus: The role of macrophages and dendritic cells in the pathogenesis of Ebola hemorrhagic fever
    Bray, M
    Geisbert, TW
    [J]. INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY, 2005, 37 (08) : 1560 - 1566
  • [10] Treatment of lethal Ebola virus infection in mice with a single dose of an S-adenosyl-L-homocysteine hydrolase inhibitor
    Bray, M
    Driscoll, J
    Huggins, JW
    [J]. ANTIVIRAL RESEARCH, 2000, 45 (02) : 135 - 147